Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Gang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4864-1451; OpenAlex author ID A5100389268. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 4 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. SAE1 May Play a Pro-Carcinogenic Role in Pancreatic Adenocarcinoma: A Comprehensive Study Integrating Multiple Pieces of Evidence. Co-author DOI 10.1049/syb2.70017↗
  2. SUMO3 inhibition by butyric acid suppresses cell viability and glycolysis and promotes gemcitabine antitumor activity in pancreatic cancer. First author DOI 10.1186/s13062-024-00513-x↗
  3. Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s10620-022-07771-7↗
  4. Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. Co-author DOI 10.1186/s12885-023-10504-2↗
  5. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. Co-author DOI 10.1186/s12885-022-10450-5↗
  6. miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4. First author DOI 10.2147/ott.s227644↗
  7. MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. Co-author DOI 10.2147/cmar.s199257↗
  8. ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways. First author DOI 10.2147/ott.s207560↗
  9. Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially‑expressed ci… Last author DOI 10.3892/ijo.2018.4660↗
  10. MicroRNA‑584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer. Co-author DOI 10.3892/mmr.2018.9651↗
  11. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1159/000494468↗
  12. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation. Co-author DOI 10.3892/mmr.2017.7945↗
  13. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Co-author DOI 10.3892/ijo.2017.3953↗
  14. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. Co-author DOI 10.18632/oncotarget.4125↗
  15. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. First author DOI 10.7314/apjcp.2014.15.7.2971↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dan‐Ming Wei · 6 shared papers, 2018–2025 · strength 0.76
  2. Yehua Shen · 3 shared papers, 2019–2024 · strength 0.50
  3. Huifeng Gao · 2 shared papers, 2020–2024 · strength 0.38
  4. Dongliang Li · 2 shared papers, 2022–2023 · strength 0.32
  5. Zhongyuan Cui · 2 shared papers, 2022–2023 · strength 0.32
  6. Zhixian Wu · 2 shared papers, 2022–2023 · strength 0.32
  7. Changjing Huang · 1 shared paper, 2024 · strength 0.26
  8. Liming Zhu · 1 shared paper, 2024 · strength 0.26
  9. Liping Zhuang · 2 shared papers, 2019–2020 · strength 0.24
  10. Dianzhong Luo · 3 shared papers, 2014–2019 · strength 0.24
  11. Su‐Ning Huang · 1 shared paper, 2025 · strength 0.22
  12. Yi Chen · 1 shared paper, 2025 · strength 0.22
  13. Xiang-Yu Gan · 1 shared paper, 2023 · strength 0.17
  14. Luming Liu · 1 shared paper, 2020 · strength 0.13
  15. Zhiqiang Meng · 1 shared paper, 2020 · strength 0.13
  16. Ye Li · 1 shared paper, 2020 · strength 0.13
  17. Yikun Qu · 1 shared paper, 2019 · strength 0.12
  18. Luming Liu · 1 shared paper, 2019 · strength 0.11
  19. Zhimin Chen · 1 shared paper, 2019 · strength 0.11
  20. Hong Yang · 1 shared paper, 2019 · strength 0.10
  21. Xiaoyong Cai · 1 shared paper, 2018 · strength 0.09
  22. Liang Liang Ma · 1 shared paper, 2018 · strength 0.09
  23. Jianjun Li · 1 shared paper, 2018 · strength 0.09
  24. Shuo Cai · 1 shared paper, 2017 · strength 0.06
  25. Lin Ye · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.